This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
What are the CE indications for BrainsWay Deep TMS?
BrainsWay Deep TMS has been cleared by the CE for a variety of disorders:
Alzheimer’s disease
Autism
Bipolar Disorder
Chronic pain
Major Depressive Disorder
Parkinson’s disease
Posttraumatic Stress Disorder (PTSD)
Schizophrenia (negative symptoms)
Smoking cessation
Stroke
Multiple Sclerosis
Obsessive Compulsive Disorder (OCD)
BrainsWay Deep TMS is cleared by the FDA for treatment resistant depression and Obsessive Compulsive Disorder (OCD).
You may also be interested in...
What evidence exists for Deep TMS effectiveness?
Numerous clinical studies in reputable peer-reviewed journals have found that BrainsWay’s Deep TMS therapy is successful in alleviating symptoms of mental health conditions and offering patients relie...
Are there any safety concerns or side effects related to Deep TMS therapy?
Deep TMS treatment is a noninvasive procedure that has been demonstrated in clinical trials and actual practice usage to be well-tolerated. You should consult your doctor to see whether dTMS is right ...
Who is eligible for Deep TMS treatment?
Deep TMS is a noninvasive treatment course proven to offer symptom relief for various mental health conditions. Eligibility for dTMS treatment is determined by a person’s insurance provider. As dTMS i...